Biological E to manufacture oral cholera vaccine for India and global markets
21 Mar 2024 //
BIOSPECTRUM ASIA
Takeda partners with India`s Biological E. to boost dengue vaccine production
26 Feb 2024 //
REUTERS
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Corbevax vaccine gets WHO Emergency Use Listing authorisation
16 Jan 2024 //
ECONOMIC TIMES
Enforcement Report - Week of September 20, 2023
20 Sep 2023 //
FDA
Biological E, Bharat Biotech together sitting on stockpile of 250 m COVID doses
27 Dec 2022 //
ECONOMIC TIMES
Biological E plans to hive off non-vaccine business and sell stake
14 Oct 2022 //
ECONOMIC TIMES
BE`s pediatric pneumonia jab gets CDSCO expert panel approval
01 Sep 2022 //
ECONOMICTIMES
Biological E`s Pneumonia jab for kids gets nod
01 Sep 2022 //
ECONOMICTIMES
Pharma Inc sets sights on monkeypox vax
17 Aug 2022 //
HEALTH ECONOMICS TIMES
100 million doses of Corbevax supplied to Centre: Biological E Ltd
12 Aug 2022 //
ECONOMICS TIMES
India to start COVID mix-and-match booster vaccines on Friday
10 Aug 2022 //
REUTERS
Corbevax approved as precaution dose for adults vaccinated with Covaxin.
10 Aug 2022 //
HEALTH ECONOMIC TIMES
Govt panel recommends Corbevax as booster for adults with Covishield, Covaxin
03 Aug 2022 //
ECONOMIC TIMES
Corbevax under WHO`s detailed review for emergency use listing`
25 Jul 2022 //
ECONOMIC TIMES
Hyderabad: Corbevax inches closer to WHO emergency use listing
15 Jul 2022 //
ET HEALTH
NTAGI likely to discuss soon data of India`s first mRNA vaccine against Covid
11 Jul 2022 //
ECONOMIC TIMES
NTAGI to discuss data of Gennova pharmaceuticals` indigenous mRNA vaccine
11 Jul 2022 //
ANI NEWS
NTAGI to decide on including Corbevax as a booster dose in inoculation drive
08 Jul 2022 //
ECONOMIC TIMES
Allowing Corbevax as booster for those vaccinated with Covishield, Covaxin
28 Jun 2022 //
ECONOMIC TIMES
Biological E gets WHO nod for production of J&J Covid vaccine
24 Jun 2022 //
ET HEALTH
India approves Biological E. COVID shot as a booster
06 Jun 2022 //
REUTERS
Biological E. Limited reduces Corbevax price to Rs 250 a dose
16 May 2022 //
ET HEALTH
Biological E seeks EUA for Corbevax booster in Covishield, Covaxin vaccinated
11 May 2022 //
ECONOMIC TIMES
Biological E asked to give more info on Corbevax for 5-12 year-olds
14 Apr 2022 //
ECONOMIC TIMES
Biological E to get mRNA technology from WHO to make COVID-19Vaccines
05 Apr 2022 //
ECONOMIC TIMES
Biological E. CCOVID shot gets India emergency approval for 12-18 age group
22 Feb 2022 //
PRESS RELEASE
BE Pharms` Generic Succinylcholine Chloride Receives Approval in the U.S.
07 Feb 2022 //
FDA
Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022
29 Dec 2021 //
EXPRESSPHARMA
Biological E gets DCGI nod for Phase 3 trials of Corbevax as booster dose
29 Dec 2021 //
DNA INDIA
Biological E soon to get EUA for Corbevax Covid vaccine
12 Nov 2021 //
PHARMABIZ
DFC to finance Biological E for expanding COVID-19 vaccine manufacturing
23 Oct 2021 //
EXPRESSPHARMA
Biological E seeks DCGI nod for Corbevax booster dose in fully vaccinated people
19 Oct 2021 //
PHARMABIZ
Biological E seeks DCGI’s nod for phase-III trial of Corbevax as booster
13 Oct 2021 //
EXPRESS PHARMA
Biological E seeks DCGI`s nod for phase-3 trial of Corbevax as booster dose
13 Oct 2021 //
ECONOMICTIMES
Biological E gets approval to manufacture J&J Covid-19 vaccine in India
17 Sep 2021 //
BUSINESS-STANDARD
Made by Biological E, J&J`s Single-Shot Covid Vaccine to Hit Market Next Month
08 Sep 2021 //
NEWS18
Biological E`s Corbevax gets nod for phase 2/3 trials on those aged 5-18
04 Sep 2021 //
ECONOMICTIMES
India gives Biological E nod to study its COVID-19 vaccine in children, teens
02 Sep 2021 //
REUTERS
Biological E to make up to 100m Corbevax vaccine doses a month
26 Jul 2021 //
FINANCIAL EXPRESS
Biological E to make up to 100m Corbevax vaccine doses a month
26 Jul 2021 //
FINANCIAL EXPRESS
4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage
19 Jul 2021 //
ECONOMIC TIMES
Biological E Announce Commercial Supply Agreement for Dynavax`s CpG 1018
07 Jul 2021 //
PR NEWSWIRE
Biological E Announce Commercial Supply Agreement for Dynavax`s CpG 1018
07 Jul 2021 //
PR NEWSWIRE
Dynavax to supply its CpG 1018 adjuvant for Biological E`s COVID-19 Vaccine
06 Jul 2021 //
ECONOMIC TIMES
Mitsubishi Tanabe Pharma Announces EXSERVAN is Now Available in the U.S.
01 Jul 2021 //
PRESS RELEASE
Providence Therapeutics Holdings Inc. Of Canada And Biological E. Limited
01 Jun 2021 //
BIOLOGICALE
India`s Biological E looking to make 600 million J&J vaccine shots a year
10 Feb 2021 //
REUTERS
CEPI Partners with Biological E. Limited to advance Development and. Manufacture of COVID-19 Vaccine candidate
31 Dec 2020 //
PRESS RELEASE
India`s Biological E. to start vaccine late-stage trials in April: Executive
19 Dec 2020 //
ECONOMIC TIMES
Indian firm Biological E initiates clinical trial of Covid-19 vaccine candidate
16 Nov 2020 //
PHARMACEUTICAL-TECHNOLOGY
Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine
16 Nov 2020 //
PRNEWSWIRE
Vaccine capital: Hyderabad set to produce a third of the world`s dosage
13 Sep 2020 //
ECONOMICTIMES
US-based BCM ties up with India`s BE for COVID-19 vaccine production
28 Aug 2020 //
ECONOMICTIMES
Baylor College & Biological E sign licensing pact to develop Covid-19 vaccine
12 Aug 2020 //
PRESS RELEASE
Biological E Signs an Agreement with Johnson & Johnson for Technology Transfer of their COVID-19 Vaccine Candidate
12 Aug 2020 //
PRESS RELEASE
Advent International emerges sole bidder for Bharat Serums
20 Jun 2019 //
ECONOMIC TIMES